VanLe L - Search Results

1

A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

Rose PG, Brunetto VL, VanLe L, Bell J, Walker JL, Lee RB. Rose PG, et al. Among authors: vanle l. Gynecol Oncol. 2000 Aug;78(2):212-6. doi: 10.1006/gyno.2000.5865. Gynecol Oncol. 2000. PMID: 10926805 Clinical Trial.

2

Expression of interleukin-1 and interleukin-1 receptor antagonists in endometrial cancer.

Van Le L, Haskill S, Jaffe GJ, Fowler WC Jr. Van Le L, et al. Gynecol Oncol. 1991 Aug;42(2):161-4. doi: 10.1016/0090-8258(91)90338-6. Gynecol Oncol. 1991. PMID: 1832651

3

Primary non-clear-cell adenocarcinomas of the vagina in older DES-exposed women.

DeMars LR, Van Le L, Huang I, Fowler WC. DeMars LR, et al. Gynecol Oncol. 1995 Sep;58(3):389-92. doi: 10.1006/gyno.1995.1249. Gynecol Oncol. 1995. PMID: 7672708

4

Pleural effusions: outpatient management with pigtail catheter chest tubes.

Van Le L, Parker LA, DeMars LR, MacKoul P, Fowler WC. Van Le L, et al. Gynecol Oncol. 1994 Aug;54(2):215-7. doi: 10.1006/gyno.1994.1196. Gynecol Oncol. 1994. PMID: 8063249

5

H-ras codon 12 mutation in cervical dysplasia.

Van Le L, Stoerker J, Rinehart CA, Fowler WC. Van Le L, et al. Gynecol Oncol. 1993 May;49(2):181-4. doi: 10.1006/gyno.1993.1104. Gynecol Oncol. 1993. PMID: 8389312

6

Lymph node metastases and prognosis in patients with stage IA2 cervical cancer.

Buckley SL, Tritz DM, Van Le L, Higgins R, Sevin BU, Ueland FR, DePriest PD, Gallion HH, Bailey CL, Kryscio RJ, Fowler W, Averette H, van Nagell JR Jr. Buckley SL, et al. Gynecol Oncol. 1996 Oct;63(1):4-9. doi: 10.1006/gyno.1996.0268. Gynecol Oncol. 1996. PMID: 8898159

7

Use of a saline breast implant to cover the pelvic floor.

Van Le L, Fowler WC. Van Le L, et al. Gynecol Oncol. 1997 Apr;65(1):188-91. doi: 10.1006/gyno.1997.4641. Gynecol Oncol. 1997. PMID: 9103413

8

Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.

Rose PG, Blessing JA, Van Le L, Waggoner S. Rose PG, et al. Gynecol Oncol. 1998 Aug;70(2):263-6. doi: 10.1006/gyno.1998.5097. Gynecol Oncol. 1998. PMID: 9740702 Clinical Trial.

9

Estrogen receptor status, determined by immunohistochemistry, as a predictor of the recurrence of stage I endometrial carcinoma.

Gehrig PA, Van Le L, Olatidoye B, Geradts J. Gehrig PA, et al. Cancer. 1999 Nov 15;86(10):2083-9. Cancer. 1999. PMID: 10570435

10

Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group Study.

Miller DS, Blessing JA, Kilgore LC, Mannel R, Van Le L. Miller DS, et al. Am J Clin Oncol. 2000 Aug;23(4):355-7. doi: 10.1097/00000421-200008000-00009. Am J Clin Oncol. 2000. PMID: 10955863 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters